Minute-scale detection of SARS-CoV-2 using a low-cost biosensor composed of pencil graphite electrodes

Lucas F. de Lima, André L. Ferreira, Marcelo D. T. Torres, William R. de Araújo, César de la Fuente‐Núñez

Proceedings of the National Academy of Sciences · 2021 · 132 citations · 42 references

DOIFull text

Open access

Concepts

Abstract

) and displays an excellent performance profile using clinical saliva (100.0% sensitivity, 100.0% specificity, and 100.0% accuracy) and nasopharyngeal/oropharyngeal (88.7% sensitivity, 86.0% specificity, and 87.4% accuracy) samples. No cross-reactivity was detected with other coronavirus or influenza strains. Importantly, LEAD also successfully diagnosed the highly contagious SARS-CoV-2 B.1.1.7 UK variant. The device presents high reproducibility under all conditions tested and preserves its original sensitivity for 5 d when stored at 4 °C in phosphate-buffered saline. Our low-cost and do-it-yourself technology opens new avenues to facilitate high-frequency testing and access to much-needed diagnostic tests in resource-limited settings and low-income communities.

References

42